Project Grant R01EB036468
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $459,264 Project Grant to The Johns Hopkins University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, which runs from Apr 8, 2025 to Feb 28, 2029, will support research and development to enhance resolution and contrast in magnetic resonance (MR) neuroimaging. This is intended to help standardize the appearance of MR neuroimages...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of extracellular vesicles (EVs) as therapeutic carriers. The $622,000 award, effective August 1, 2024 through July 31, 2027, will enable researchers at The Washington University in St. Louis to engineer endothelial cell-derived EVs to efficiently...
- This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31,...
- This $165,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research and development of magnetic spinal cord stimulation (MSCS) technologies. The project aims to model and assess the safety of MSCS, an emerging neuromodulation technique that uses external coils to induce electric fields in the spinal cord. Unlike...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,161,839 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Wisconsin System for the project "MRI Technology for Greater Efficiency and Improved Value". The overall goal is to design technologies that improve the value of MRI by enhancing efficiency, accessibility, safety, and user experience. Key...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $541,109 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Washington. The 5-year grant, beginning January 1, 2025, will fund research to quantify myelin loss and recovery in ischemic stroke patients using a novel magnetic resonance imaging (MRI) technique called single-point macromolecular proton fraction (MPF) mapping. The...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $729,703 to The Trustees of Columbia University in the City of New York to develop a technology called "NanoVials" to sort and enrich mesenchymal stem cells (MSCs) based on their extracellular vesicle (EV) secretion levels. The goal is to optimize stem cell therapies for ischemic diseases like myocardial infarction by identifying and utilizing MSCs with...
- The Project Grant award of $535,416 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports the development of a technological toolkit for noninvasive mapping of ionic activity in the mouse brain. The goal is to create a voltage-sensing nanoprobe using DNA nanoparticles, indocyanine green dye, and a quencher, which can provide high-resolution...
- The federal Project Grant award R56EB033347, in the amount of $499,291.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The award will support the development of breakthrough technology to enable future compact, mid-field (0.7 Tesla) magnetic resonance imaging (MRI) systems, with the goal of improving accessibility and...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $663,854 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to the University of Miami for research titled "Quantitative Dynamic Monitoring of MSCs and MSC-EVs in a Mouse Model of Intracerebral Hemorrhage". The project aims to investigate the use of magnetic particle imaging (MPI) to non-invasively and quantitatively monitor the biodistribution and therapeutic effectiveness of mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (MSC-EVs) in treating intracerebral hemorrhage, a severe form of stroke, in a mouse model. The award period runs from August 1, 2025 to April 30, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $663.9k | 7/25/25 |